Grifols, S.A Shares Outstanding 2012-2020 | GRFS

Grifols, S.A shares outstanding history from 2012 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Grifols, S.A shares outstanding for the quarter ending September 30, 2020 were M, a 100% decline year-over-year.
  • Grifols, S.A 2020 shares outstanding were 0.685B, a 0.06% increase from 2019.
  • Grifols, S.A 2019 shares outstanding were 0.685B, a 0% decline from 2018.
  • Grifols, S.A 2018 shares outstanding were 0.685B, a 0.06% increase from 2017.
Grifols, S.A Annual Shares Outstanding
(Millions of Shares)
2020 685
2019 685
2018 685
2017 684
2016 683
2015 686
2014 687
2013 684
2012 685
2011 556
Grifols, S.A Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30
2019-06-30 690
2018-06-30 675
2017-06-30 685
2017-03-31 670
2016-12-31 683
2016-09-30 675
2016-06-30 696
2016-03-31 696
2015-12-31
2015-09-30 683
2015-06-30 682
2015-03-31 676
2014-12-31 691
2014-09-30 692
2014-06-30 692
2014-03-31 691
2013-12-31 714
2013-09-30 674
2013-06-30 673
2013-03-31 663
2012-12-31 791
2012-09-30 670
2012-06-30 693
2012-03-31 675
2011-12-31 912
2011-09-30 572
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.039B $6.099B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.190B 42.21
Takeda Pharmaceutical (TAK) Japan $54.120B 9.91
Astellas Pharma (ALPMY) Japan $27.759B 17.14
Eisai (ESALY) Japan $19.686B 21.84
Catalent (CTLT) United States $18.619B 49.27
Jazz Pharmaceuticals (JAZZ) Ireland $9.140B 15.27
United Therapeutics (UTHR) United States $8.846B 17.18
Neurocrine Biosciences (NBIX) United States $8.772B 20.22
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
IPSEN SA ADR (IPSEY) France $7.479B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.516B 0.00
Evotec AG (EVTCY) Germany $6.289B 424.67
Orion OYJ (ORINY) Finland $5.789B 20.11
Ionis Pharmaceuticals (IONS) United States $5.757B 0.00
Sage Therapeutics (SAGE) United States $4.360B 0.00
Hypermarcas (HYPMY) Brazil $3.883B 15.32
Turning Point Therapeutics (TPTX) United States $3.671B 0.00
Nektar Therapeutics (NKTR) United States $3.405B 0.00
PTC Therapeutics (PTCT) United States $3.314B 0.00
ChemoCentryx (CCXI) United States $3.230B 0.00
Pacira BioSciences (PCRX) United States $2.981B 50.33
Relay Therapeutics (RLAY) United States $2.962B 0.00
Tilray (TLRY) Canada $2.953B 0.00
Cronos Group (CRON) Canada $2.943B 0.00
Organogenesis Holdings (ORGO) United States $2.941B 176.77
Revolution Medicines (RVMD) United States $2.880B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.777B 17.20
Corcept Therapeutics (CORT) United States $2.631B 26.39
Xencor (XNCR) United States $2.294B 0.00
USANA Health Sciences (USNA) United States $2.075B 17.17
FibroGen (FGEN) United States $1.821B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.730B 11.10
BioCryst Pharmaceuticals (BCRX) United States $1.686B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.635B 12.86
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.611B 0.00
Sundial Growers (SNDL) Canada $1.544B 0.00
Heron Therapeutics (HRTX) United States $1.489B 0.00
AlloVir (ALVR) United States $1.482B 0.00
ImmunoGen (IMGN) United States $1.434B 0.00
Aclaris Therapeutics (ACRS) United States $1.423B 0.00
Endo (ENDP) Ireland $1.422B 2.15
Theravance Biopharma (TBPH) Cayman Islands $1.340B 0.00
Indivior (INVVY) United States $1.338B 0.00
Translate Bio (TBIO) United States $1.288B 0.00
Ocular Therapeutix (OCUL) United States $1.232B 0.00
Zogenix (ZGNX) United States $1.055B 0.00
Trillium Therapeutics (TRIL) Canada $1.017B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.978B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
4D Molecular Therapeutics (FDMT) $0.919B 0.00
Radius Health (RDUS) United States $0.886B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Aerie Pharmaceuticals (AERI) United States $0.864B 0.00
Collegium Pharmaceutical (COLL) United States $0.802B 29.99
Bioventus (BVS) United States $0.784B 0.00
Karyopharm Therapeutics (KPTI) United States $0.748B 0.00
Esperion Therapeutics (ESPR) United States $0.727B 0.00
Ardelyx (ARDX) United States $0.694B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Rafael Holdings (RFL) United States $0.688B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.679B 0.00
Harpoon Therapeutics (HARP) United States $0.656B 0.00
VAXART, INC (VXRT) United States $0.615B 0.00
KalVista Pharmaceuticals (KALV) United States $0.613B 0.00
Chinook Therapeutics (KDNY) United States $0.576B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.565B 0.00
Nanobiotix S.A (NBTX) France $0.551B 0.00
Sigilon Therapeutics (SGTX) $0.549B 0.00
Siga Technologies (SIGA) United States $0.543B 9.08
Rigel Pharmaceuticals (RIGL) United States $0.526B 0.00
TherapeuticsMD (TXMD) United States $0.515B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.512B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.493B 0.00
Altimmune (ALT) United States $0.467B 0.00
Akebia Therapeutics (AKBA) United States $0.457B 0.00
Summit Therapeutics (SMMT) United States $0.454B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.452B 0.00
Foghorn Therapeutics (FHTX) United States $0.447B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.445B 10.46
AVITA Medical (RCEL) United States $0.445B 0.00
Molecular Templates (MTEM) United States $0.438B 0.00
Flexion Therapeutics (FLXN) United States $0.415B 0.00
Jounce Therapeutics (JNCE) United States $0.414B 0.00
PROFOUND MEDICL (PROF) Canada $0.405B 0.00
DURECT (DRRX) United States $0.395B 0.00
Nature's Sunshine Products (NATR) United States $0.389B 18.53
MEI Pharma (MEIP) United States $0.381B 0.00
Acutus Medical (AFIB) United States $0.350B 0.00
Innate Pharma SA (IPHYF) France $0.347B 0.00
Oncternal Therapeutics (ONCT) United States $0.334B 0.00
Redhill Biopharma (RDHL) Israel $0.325B 0.00
VYNE Therapeutics (VYNE) United States $0.306B 0.00
Clever Leaves Holdings (CLVR) United States $0.287B 0.00
Infinity Pharmaceuticals (INFI) United States $0.266B 0.00
CASI Pharmaceuticals (CASI) United States $0.263B 0.00
Taiwan Liposome (TLC) Taiwan $0.248B 0.00
Alpine Immune Sciences (ALPN) United States $0.248B 0.00
KemPharm (KMPH) United States $0.247B 0.00
Xeris Pharmaceuticals (XERS) United States $0.235B 0.00
Inotiv (NOTV) United States $0.228B 0.00
Progenity (PROG) United States $0.226B 0.00
Jaguar Animal Health (JAGX) United States $0.221B 0.00
Iterum Therapeutics (ITRM) Ireland $0.221B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.219B 0.00
Lannett Co Inc (LCI) United States $0.214B 7.18
Dipexium Pharmaceuticals (PLXP) United States $0.214B 0.00
Novan (NOVN) United States $0.209B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.206B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.200B 0.00
Sierra Oncology (SRRA) Canada $0.197B 0.00
IMV INC (IMV) Canada $0.191B 0.00
CTI BioPharma (CTIC) United States $0.186B 0.00
OptiNose (OPTN) United States $0.183B 0.00
Heat Biologics (HTBX) United States $0.176B 0.00
Onconova Therapeutics (ONTX) United States $0.170B 0.00
SCYNEXIS (SCYX) United States $0.169B 0.00
Vivos Therapeutics (VVOS) $0.167B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.164B 0.00
Calithera Biosciences (CALA) United States $0.164B 0.00
Qilian Holding Group (QLI) China $0.159B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
Adherex Technologies (FENC) United States $0.159B 0.00
Champions Oncology (CSBR) United States $0.152B 0.00
Aquestive Therapeutics (AQST) United States $0.150B 0.00
Concert Pharmaceuticals (CNCE) United States $0.146B 0.00
MediWound (MDWD) Israel $0.143B 0.00
IsoRay (ISR) United States $0.143B 0.00
Nutriband (NTRB) United States $0.140B 0.00
Genocea Biosciences (GNCA) United States $0.139B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.138B 0.00
GlycoMimetics (GLYC) United States $0.133B 0.00
Aziyo Biologics (AZYO) United States $0.133B 0.00
Lipocine (LPCN) United States $0.130B 0.00
PolarityTE (PTE) United States $0.115B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.114B 0.00
Natural Alternatives (NAII) United States $0.111B 30.17
La Jolla Pharmaceutical (LJPC) United States $0.108B 0.00
Otonomy (OTIC) United States $0.107B 0.00
Minerva Neurosciences (NERV) United States $0.103B 40.33
AIM ImmunoTech (AIM) United States $0.103B 0.00
Regulus Therapeutics (RGLS) United States $0.101B 0.00
Recro Pharma (REPH) United States $0.099B 0.00
Savara (SVRA) United States $0.096B 0.00
Assertio Holdings (ASRT) United States $0.095B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.095B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.082B 0.00
ProPhase Labs (PRPH) United States $0.078B 0.00
Baudax Bio (BXRX) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.074B 0.00
India Globalization Capital (IGC) United States $0.073B 0.00
Addex Therapeutics (ADXN) Switzerland $0.070B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.069B 0.00
Sigyn Therapeutics (SIGY) United States $0.067B 0.00
Brickell Biotech (BBI) United States $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
AgeX Therapeutics (AGE) United States $0.061B 0.00
Biomerica (BMRA) United States $0.061B 0.00
IntelGenx Technologies (IGXT) Canada $0.059B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.058B 0.00
Inhibikase Therapeutics (IKT) United States $0.056B 0.00
HANCOCK JAFFE (HJLI) United States $0.056B 0.00
CV Sciences (CVSI) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 60.20
Viracta Therapeutics (VIRX) United States $0.043B 0.00
Mannatech (MTEX) United States $0.042B 7.49
Can-Fite Biopharma (CANF) Israel $0.040B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.035B 0.00
4D Pharma (LBPS) United Kingdom $0.033B 0.00
RXi Pharmaceuticals (PHIO) United States $0.033B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Petros Pharmaceuticals (PTPI) United States $0.030B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.028B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
JanOne (JAN) United States $0.021B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 16.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
SHINECO INC (TYHT) China $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00